Encision Inc. Announces Fiscal 2026 Third Quarter Results
-
Brussels Education Unions Schedule Major November Protest Over Funding and Reforms
-
Crowds Gather at San Francisco Park for Elizabeth Holmes Lookalike Tournament
-
iPS Cell Research Accelerates Drug Discovery for ALS and Spinal Cord Injury
-
Central Tokyo Apartment Rents Forecast to Rise 11% by 2030
-
Rene Eyre Revisits Autobiographical Performance 'Say A Little Prayer' in London
-
London Museum Granted 24/7 License Ahead of November Opening
-
UAE's HCT Holds Record Graduation and Announces Major Training Expansion
-
Dana White Confirms Flight to Washington for Trump Meeting on Press Secretary Role
-
NASA Awards $10B Lunar Contract Framework to SpaceX, Blue Origin
-
Dengue Fever Expands Into High Himalayas as Climate Change Warms Nepal
-
Katy Perry Tells Fans Ex-Husband Russell Brand 'Should Be in Jail' During UK Concert
-
IoT Refrigerator Hacks Disrupt Blood Labs and Supermarkets Across Europe and US
Encision Inc. Announces Fiscal 2026 Third Quarter Results
BOULDER, CO / ACCESS Newswire / February 4, 2026 / Encision Inc. (OTC PINK:ECIA), a medical device company owning patented Active Electrode Monitoring (AEM®) Technology that prevents dangerous radiant energy burns in minimally invasive surgery, today reported its financial results for its 2026 fiscal third quarter.
Encision's CEO Robert Fries commented, "The Company's revenue has continued to decline principally because of procedures that were performed by surgical robots that have replaced our surgical procedures. Looking forward, we expect that this revenue decrease will continue. Gross profit margin percent decreased significantly in the third quarter because of a large increase to the inventory reserve. We are currently performing a restructuring and have reduced operating expenses substantially. This decrease will be recognized in the fourth quarter."
Encision designs and markets a portfolio of high-performance surgical instrumentation that delivers advances in patient safety with AEM technology, surgical performance, and value to hospitals across a broad range of minimally invasive surgical procedures. Based in Boulder, Colorado, the company pioneered the development and deployment of Active Electrode Monitoring, AEM technology, to eliminate dangerous stray energy burns during minimally invasive procedures.
Encision Inc.
Condensed Statements of Operations
(unaudited)
Quarters ended | Variance | |||||||||||
(in $ thousands) | Dec. 31, 2025 | Sep. 30, 2025 | ($) | (%) | ||||||||
Net sales | 1,413 | 1,528 | -115 | -7.5 | % | |||||||
Cost of goods sold | 870 | 831 | 39 | 4.7 | % | |||||||
Gross profit | 543 | 697 | -154 | -22.1 | % | |||||||
Gross profit margin % | 38.4 | % | 45.6 | % | -7.2 | % | ||||||
Operating expenses | 842 | 956 | -114 | -11.9 | % | |||||||
Operating income | (299 | ) | (259 | ) | (40 | ) | -15.4 | % | ||||
Operating margin % | -21.2 | % | -17.0 | % | -4.2 | % | ||||||
Interest and other expense, net | (15 | ) | (9 | ) | -6 | |||||||
Net loss | (314 | ) | (268 | ) | (46 | ) | -17.2 | % | ||||
CONTACT: Mala Ray, Encision Inc, 303-444-2600, [email protected]
SOURCE: Encision, Inc.
View the original press release on ACCESS Newswire
A.Rodriguezv--AMWN
